Latest AI and machine learning research in psychiatry for healthcare professionals.
Major depressive disorder (MDD) with suicidality represents a significant public health concern, as suicide ranks among the leading causes of death worldwide. While electroencephalography (EEG) has shown promise in depression diagnosis, its utility in identifying suicidal risk remains underexplored. This study aims to develop and validate a Suicidal Risk Index (SR Index) using EEG biomarkers and m...
Alzheimers disease (AD) remains a major global health challenge, with growing evidence linking chronic infections, immune aging, and neurodegeneration. Grounded in the Antimicrobial Protection Hypothesis, this study introduces a sheaf-theoretic machine learning framework, Sheaf-ML, for integrating multimodal health data and assessing infection-related cognitive risk. Sheaf-ML constructs a unified ...
Detecting schizophrenia (SZ) from electroencephalography (EEG) signals using machine- and deep learning models gained traction lately due to potential...
Deviations from normative brain ageing trajectories are linked to a wide range of adverse health outcomes. A number of brain age prediction models hav...
Assistants incorporating large language models are increasingly applied in the context of health care, where they represent a promising means of expan...
Living with multiple long-term conditions (MLTC) profoundly impacts patients’ lives, affecting not only their health but also their financial, emotion...
Cognitive dysfunction often co-occurs with psychopathology. Advances in neuroimaging and machine learning have led to neural indicators that predict i...
The large language model (LLM) chatbot product ChatGPT has accumulated 800 million weekly users since its 2022 launch. In 2025, several media outlets ...
Cerebral small vessel disease (CSVD) is a leading cause of age-related cognitive decline and neurological disorders, yet its precise characterization ...
To identify clusters of high-cost patients in England based on diagnoses and sociodemographic characteristics to inform targeted population health man...
Perinatal depression affects up to 30% of pregnant and postpartum women, which has increased since the COVID-19 pandemic, making rapidly identifying a...
Schizophrenia (SCZ) is associated with widespread gray matter volume (GMV) reductions, yet the underlying mechanisms driving these alterations remain ...
Use of coercive measures in psychiatric hospitals is clinically and ethically challenging. Aiming to support prevention, we developed and evaluated ma...
Artificial Intelligence (AI) voice applications have the potential to address the unmet treatment needs among patients with depression and anxiety, bu...
Depression is a leading cause of global disability. Timely identification of patients at risk for clinical worsening remains a major challenge. Electr...
This study introduces a novel transformer-based ensemble framework for the multi-label detection of mental health disorders from social media posts. U...
Major depressive disorder (MDD) affects millions worldwide, yet its neurobiological underpinnings remain elusive. Neuroimaging studies have yielded in...
Antidepressant use is common in people with dementia. Antidepressants may be started to manage symptoms of dementia, rather than depressive and anxiet...
Clinical practice guidelines support evidence-based care but are often underused due to complexity, time constraints, and navigation challenges. We in...
The course of psychotic disorders typically involves relapses. Early warning signs vary between individuals and are difficult to detect in clinical pr...